Roivant Sciences

56 followers

Roivant Sciences is a biopharmaceutical company focused on realizing the full value of promising drug candidates to improve the lives of patients.

Industries

Employees

201-500

Links


Org chart

Hiring!

Matt Gline
CEO
Collapse
Eric Venker
President & COO
Mayukh Sukhatme
President & Chief Investment Officer
Drew Kramer
Chief Information Officer
Jo Chen
General Counsel
Alex Gasner
EVP, Roivant Health
Vacant position
Elaine Wu
Director
Ruby Grewal
Executive In Residence
Gavin Corcoran
Chief R&D Officer, Axovant
John Alfano
Chief Operating Officer, Lokavant
Ian Rosenblum
Chief Information Officer
David Nassif
CFO, Axovant
Colin Bower
Chief Commercial Officer, Lokavant
Huafeng Xu
Chief Technology Officer, Roivant Discovery
Mitchell Mittman
CTO, Alyvant
Julie Edelstein
Executive Business Partner
Chris Chapman
Chief Commercial Officer, Dermavant
Julia G. Butchko
Chief Development & Technology Officer, Immunovant
Michael J. Elliot
Chief Scientific Officer, Immunovant
Mat Bazley
General Counsel, Axovant
Stephanie Lee Griffin
Coo, Roivant Platforms
William Chou
CEO Aruvant
William H. Collier
CEO, Arbutus
Pete Salzmann
CEO, Immunovant
Travis May
CEO, Datavant
Peter Lutwyche
CEO, Genevant
Todd Zavodnick
CEO Dermavant
Lindsay Androski
CEO, Roivant Social Ventures
Michael Swartzburg
CFO, Dermavant
Nick Colburn
Chief Financial Officer, Datavant
Steve Swank
CRO, Datavant
Pravin Soni
EVP, Development & Manufacturing, Respivant
Elizabeth Czerepak
Chief Financial Officer, Genevant
David Rubenstein
Chief Scientific Officer, Dermavant
Michael Sofia
Chief Scientific Officer, Arbutus
Rae Yuan
President, Sinovant
Joseph McIntosh
Chief Medical Officer, Aruvant
Bill Macias
Chief Medical Officer, Immunovant
Ahmet Tutuncu
EVP, Clinical & Regulatory, Respivant
Chris Van Tuyl
General Counsel, Dermavant
Philip Brown
Chief Medical Officer, Dermavant
Aden Fine
General Counsel, Datavant
Jason Labonte
Chief Strategy Officer, Datavant
James Heyes
Chief Scientific Officer, Genevant
Bryan Smith
General Counsel, Urovant
Brad Middlekauff
General Counsel, Immunovant
Gaston Picchio
Chief Development Officer, Arbutus
Deya Corzo
Chief Medical Officer-In-Residence

Board & advisors

Andrew Fromkin
Board Member, Immunovant
Atul Pande
Board Member, Axovant, Immunovant
Berndt Modig
Board Member, Axovant
Douglas Hughes
Board Member, Immunovant
George Migausky
Board Member, Immunovant
Ilan Oren
Board Member, Axovant, Roivant
Keith Manchester
Board Member, Roivant
Pete Rouse
Advisor
Sakshi Chhabra
Board Member, Roivant
Senthil Sundaram
Board Member, Axovant
Daniel Gold
Director